Reuse of osimertinib after small cell lung cancer transformation in lung adenocarcinoma with de-novo epidermal growth factor receptor T790M mutation: case report

Department of Oncology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China

Received 29 July 2022 Revised form accepted 29 July 2022

*Xiuwen Wang and Jizhen Liang contributed equally to the writing of this article.

Correspondence to Lin Wang, MD, Department of Oncology, Guangzhou Red Cross Hospital, Jinan University, No.396 Tongfu Middle Road, Haizhu District, Guangzhou 510220, China, Tel: +8613631484609; e-mail: [email protected]

留言 (0)

沒有登入
gif